Skip to main content

Raynaud’s Mimics

  • Chapter
  • First Online:
Raynaud’s Phenomenon

Abstract

Raynaud’s phenomenon is a common feature among many autoimmune conditions and is often used to support the diagnosis of a rheumatic disease. Temperature sensitivity and digital discoloration, two key features of Raynaud’s, are shared by several other conditions which may complicate a clinical evaluation. An accurate diagnosis of Raynaud’s is critical in risk stratifying patients with early rheumatic disease and determining appropriate management. Physicians and other health care providers must be aware of these “mimics” and clearly distinguish them from Raynaud’s. This chapter begins with a detailed review of each of these conditions which include frostbite, primary pernio/chilblains, chilblain lupus, acrocyanosis, livedo reticularis and racemosa, and erythromelalgia.

Subsequently, the chapter will address other mimics of Raynaud’s that are also associated with digital color changes, but are distinguished from Raynaud’s by an absence of temperature sensitivity. Thoracic outlet syndrome and complex regional pain syndrome are both discussed in detail and important features of diagnosis and management are revealed. Thoracic outlet syndrome is important to accurately diagnose as it can be reversed with surgical intervention. Out of the three subtypes, arterial TOS is most important to quickly refer to a surgeon. Complex regional pain syndrome can have similar features to Raynaud’s, but the quality of the pain is the most distinguishing symptom.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CRPS:

Complex regional pain syndrome

FRRS:

First rib resection and anterior scalenectomy

IASP:

International Association for the Study of Pain

QSART:

Quantitative sudomotor axon reflex tear

RSO:

Resting sweat output

RST:

Resting skin temperature

TOS:

Thoracic outlet syndrome

TRVP:

Transient receptor vanilloid channels

References

  1. Harirchi I, Arvin A, Vash JH, Zafarmand V. Frostbite: incidence and predisposing factors in mountaineers. Br J Sports Med. 2005;39(12):898–901. discussion 901.

    PubMed  CAS  PubMed Central  Google Scholar 

  2. Long 3rd WB, Edlich RF, Winters KL, Britt LD. Cold injuries. J Long Term Eff Med Implants. 2005;15(1):67–78.

    PubMed  Google Scholar 

  3. Woo EK, Lee JW, Hur GY, Koh JH, Seo DK, Choi JK, et al. Proposed treatment protocol for frostbite: a retrospective analysis of 17 cases based on a 3-year single-institution experience. Arch Plast Surg. 2013;40(5):510–6.

    PubMed  PubMed Central  Google Scholar 

  4. Imray CH, Oakley EH. Cold still kills: cold-related illnesses in military practice freezing and non-freezing cold injury. J R Army Med Corps. 2005;151(4):218–22.

    PubMed  CAS  Google Scholar 

  5. Valnicek SM, Chasmar LR, Clapson JB. Frostbite in the prairies: a 12-year review. Plast Reconstr Surg. 1993;92(4):633–41.

    PubMed  CAS  Google Scholar 

  6. Imray CH, Richards P, Greeves J, Castellani JW. Nonfreezing cold-induced injuries. J R Army Med Corps. 2011;157(1):79–84.

    PubMed  CAS  Google Scholar 

  7. Hallam MJ, Cubison T, Dheansa B, Imray C. Managing frostbite. BMJ. 2010;341:c5864.

    PubMed  Google Scholar 

  8. Johnson-Arbor K. Images in clinical medicine. Digital frostbite. N Engl J Med. 2014;370(2):e3.

    PubMed  Google Scholar 

  9. Khan MI, Tariq M, Rehman A, Zafar A, Sheen SN. Efficacy of cervicothoracic sympathectomy versus conservative management in patients suffering from incapacitating Raynaud’s syndrome after frost bite. J Ayub Med Coll Abbottabad. 2008;20(2):21–4.

    PubMed  Google Scholar 

  10. Bouwman DL, Morrison S, Lucas CE, Ledgerwood AM. Early sympathetic blockade for frostbite – is it of value? J Trauma. 1980;20(9):744–9.

    PubMed  CAS  Google Scholar 

  11. Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med. 2011;364(2):189–90.

    PubMed  CAS  Google Scholar 

  12. Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma. 2005;59(6):1350–4. discussion 1354–5.

    PubMed  CAS  Google Scholar 

  13. Sheridan RL, Goldstein MA, Stoddard Jr FJ, Walker TG. Case records of the Massachusetts General Hospital. Case 41-2009. A 16-year-old boy with hypothermia and frostbite. N Engl J Med. 2009; 361(27):2654–62.

    PubMed  CAS  Google Scholar 

  14. Finderle Z, Cankar K. Delayed treatment of frostbite injury with hyperbaric oxygen therapy: a case report. Aviat Space Environ Med. 2002;73(4):392–4.

    PubMed  Google Scholar 

  15. von Heimburg D, Noah EM, Sieckmann UP, Pallua N. Hyperbaric oxygen treatment in deep frostbite of both hands in a boy. Burns. 2001;27(4):404–8.

    Google Scholar 

  16. Miller MB, Koltai PJ. Treatment of experimental frostbite with pentoxifylline and aloe vera cream. Arch Otolaryngol Head Neck Surg. 1995;121(6):678–80.

    PubMed  CAS  Google Scholar 

  17. Hayes Jr DW, Mandracchia VJ, Considine C, Webb GE. Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite. Clin Podiatr Med Surg. 2000;17(4):715–22.

    PubMed  Google Scholar 

  18. Johnson AR, Jensen HL, Peltier G, DelaCruz E. Efficacy of intravenous tissue plasminogen activator in frostbite patients and presentation of a treatment protocol for frostbite patients. Foot Ankle Spec. 2011;4(6):344–8.

    PubMed  Google Scholar 

  19. Taylor MS. Lumbar epidural sympathectomy for frostbite injuries of the feet. Mil Med. 1999; 164(8):566–7.

    PubMed  CAS  Google Scholar 

  20. Chandran GJ, Chung B, Lalonde J, Lalonde DH. The hyperthermic effect of a distal volar forearm nerve block: a possible treatment of acute digital frostbite injuries? Plast Reconstr Surg. 2010;126(3):946–50.

    PubMed  CAS  Google Scholar 

  21. Jacob JR, Weisman MH, Rosenblatt SI, Bookstein JJ. Chronic pernio. A historical perspective of cold-induced vascular disease. Arch Intern Med. 1986; 146(8):1589–92.

    PubMed  CAS  Google Scholar 

  22. Prakash S, Weisman MH. Idiopathic chilblains. Am J Med. 2009;122(12):1152–5.

    PubMed  Google Scholar 

  23. Goette DK. Chilblains (perniosis). J Am Acad Dermatol. 1990;23(2 Pt 1):257–62.

    PubMed  CAS  Google Scholar 

  24. Larkins N, Murray KJ. Major cluster of chilblain cases in a cold dry Western Australian winter. J Paediatr Child Health. 2013;49(2):144–7.

    PubMed  Google Scholar 

  25. Page EH, Shear NH. Temperature-dependent skin disorders. J Am Acad Dermatol. 1988;18(5 Pt 1):1003–19.

    PubMed  CAS  Google Scholar 

  26. Takci Z, Vahaboglu G, Eksioglu H. Epidemiological patterns of perniosis, and its association with systemic disorder. Clin Exp Dermatol. 2012;37(8):844–9.

    PubMed  CAS  Google Scholar 

  27. Simon TD, Soep JB, Hollister JR. Pernio in pediatrics. Pediatrics. 2005;116(3):e472–5.

    PubMed  Google Scholar 

  28. Padeh S, Gerstein M, Greenberger S, Berkun Y. Chronic chilblains: the clinical presentation and disease course in a large paediatric series. Clin Exp Rheumatol. 2013;31(3):463–8.

    PubMed  Google Scholar 

  29. Klippel JH. Raynaud’s phenomenon. The French tricolor. Arch Intern Med. 1991;151(12):2389–93.

    PubMed  CAS  Google Scholar 

  30. Arias-Santiago SA, Giron-Prieto MS, Callejas-Rubio JL, Fernandez-Pugnaire MA, Ortego-Centeno N. Lupus pernio or chilblain lupus?: two different entities. Chest. 2009;136(3):946–7. author reply 947.

    PubMed  Google Scholar 

  31. Vano-Galvan S, Martorell A. Chilblains. CMAJ. 2012;184(1):67.

    PubMed  PubMed Central  Google Scholar 

  32. Cribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol. 2001;45(6):924–9.

    PubMed  CAS  Google Scholar 

  33. Dowd PM, Rustin MH, Lanigan S. Nifedipine in the treatment of chilblains. Br Med J (Clin Res Ed). 1986;293(6552):923–4.

    CAS  Google Scholar 

  34. Rustin MH, Newton JA, Smith NP, Dowd PM. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol. 1989;120(2):267–75.

    PubMed  CAS  Google Scholar 

  35. Spittell Jr JA, Spittell PC. Chronic pernio: another cause of blue toes. Int Angiol. 1992;11(1):46–50.

    PubMed  Google Scholar 

  36. Viguier M, Pinquier L, Cavelier-Balloy B, de la Salmoniere P, Cordoliani F, Flageul B, et al. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine (Baltimore). 2001;80(3):180–8.

    CAS  Google Scholar 

  37. Souwer IH, Lagro-Janssen AL. Chronic chilblains. BMJ. 2011;342:d2708.

    PubMed  CAS  Google Scholar 

  38. Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, et al. Chilblain lupus erythematosus – a review of literature. Clin Rheumatol. 2008;27(10):1341.

    PubMed  Google Scholar 

  39. Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;80(4):811–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  40. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007;39(9):1065–7.

    PubMed  CAS  Google Scholar 

  41. Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007;85(5):531–7.

    CAS  Google Scholar 

  42. Tungler V, Silver RM, Walkenhorst H, Gunther C, Lee-Kirsch MA. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol. 2012;167(1):212–4.

    PubMed  CAS  Google Scholar 

  43. Su WP, Perniciaro C, Rogers 3rd RS, White Jr JW. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis. 1994;54(6): 395–9.

    PubMed  CAS  Google Scholar 

  44. Boehm I, Bieber T. Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol. 2001;137(2):235–6.

    PubMed  CAS  Google Scholar 

  45. Millard LG, Rowell NR. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients. Br J Dermatol. 1978;98(5):497–506.

    PubMed  CAS  Google Scholar 

  46. Kurklinsky AK, Miller VM, Rooke TW. Acrocyanosis: the Flying Dutchman. Vasc Med. 2011;16(4):288–301.

    PubMed  PubMed Central  Google Scholar 

  47. Neri P, Messerotti A, Lonardo A, Capatti C, Melini L. Acrocyanosis as a heralding sign of ovarian benign teratoma. Am J Hematol. 1996;53(1):53.

    PubMed  CAS  Google Scholar 

  48. Legrain S, Raguin G, Piette JC. Digital necrosis revealing ovarian cancer. Dermatology. 1999;199(2):183–4.

    PubMed  CAS  Google Scholar 

  49. Poszepczynska-Guigne E, Viguier M, Chosidow O, Orcel B, Emmerich J, Dubertret L. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47(1):47–52.

    PubMed  Google Scholar 

  50. Chow SF, McKenna CH. Ovarian cancer and gangrene of the digits: case report and review of the literature. Mayo Clin Proc. 1996;71(3):253–8.

    PubMed  CAS  Google Scholar 

  51. Anderson RP, Morris BA. Acrocyanosis due to imipramine. Arch Dis Child. 1988;63(2):204–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  52. Karakaya I, Aydogan M, Coskun A, Gokalp AS. Acrocyanosis as a side effect of tricyclic antidepressants: a case report. Turk J Pediatr. 2003;45(2):155–7.

    PubMed  Google Scholar 

  53. Campo-Voegeli A, Estrach T, Marti RM, Corominas N, Tuset M, Mascaro JM. Acrocyanosis induced by interferon alpha(2a). Dermatology. 1998;196(3):361–3.

    PubMed  CAS  Google Scholar 

  54. Dickerman JD, Howard P, Dopp S, Staley R. Infectious mononucleosis initially seen as cold-induced acrocyanosis: association with auto-anti-M and anti-I antibodies. Am J Dis Child. 1980;134(2):159–60.

    PubMed  CAS  Google Scholar 

  55. Heidrich H. Functional vascular diseases: Raynaud’s syndrome, acrocyanosis and erythromelalgia. Vasa. 2010;39(1):33–41.

    PubMed  CAS  Google Scholar 

  56. Parsi K, Partsch H, Rabe E, Ramelet AA. Reticulate eruptions: part 2. Historical perspectives, morphology, terminology and classification. Australas J Dermatol. 2011;52(4):237–44.

    PubMed  Google Scholar 

  57. Thornsberry LA, LoSicco KI, English 3rd JC. The skin and hypercoagulable states. J Am Acad Dermatol. 2013;69(3):450–62.

    PubMed  Google Scholar 

  58. Kraemer M, Linden D, Berlit P. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol. 2005;252(10):1155–66.

    PubMed  Google Scholar 

  59. Gibbs MB, English 3rd JC, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005; 52(6):1009–19.

    PubMed  Google Scholar 

  60. Parsi K, Partsch H, Rabe E, Ramelet AA. Reticulate eruptions. Part 1: vascular networks and physiology. Australas J Dermatol. 2011;52(3):159–66.

    PubMed  Google Scholar 

  61. Asherson RA, Cervera R, Shepshelovich D, Shoenfeld Y. Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? J Rheumatol. 2006;33(6):1038–44.

    PubMed  Google Scholar 

  62. Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, et al. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol. 2006;24((1 Suppl 40)):S46–51.

    PubMed  CAS  Google Scholar 

  63. Frances C, Niang S, Laffitte E, Pelletier F, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52(6):1785–93.

    PubMed  Google Scholar 

  64. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33(12):2379–82.

    PubMed  Google Scholar 

  65. Hughes GR. Autoantibodies in lupus and its variants: experience in 1000 patients. Br Med J (Clin Res Ed). 1984;289(6441):339–42.

    CAS  Google Scholar 

  66. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol. 1987;123(5):596–600.

    PubMed  CAS  Google Scholar 

  67. Weinstein S, Piette W. Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am. 2008;22(1):67–77. vi.

    PubMed  Google Scholar 

  68. Waxman SG, Dib-Hajj SD. Erythromelalgia: a hereditary pain syndrome enters the molecular era. Ann Neurol. 2005;57(6):785–8.

    PubMed  Google Scholar 

  69. Skeik N, Rooke TW, Davis MD, Davis DM, Kalsi H, Kurth I, et al. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation. Vasc Med. 2012;17(1):44–9.

    PubMed  Google Scholar 

  70. Egri C, Ruben PC. A hot topic: temperature sensitive sodium channelopathies. Channels (Austin). 2012;6(2):75–85.

    CAS  Google Scholar 

  71. Davis MD, O’Fallon WM, Rogers 3rd RS, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136(3):330–6.

    PubMed  CAS  Google Scholar 

  72. van Genderen PJ, Michiels JJ, Drenth JP. Hereditary erythermalgia and acquired erythromelalgia. Am J Med Genet. 1993;45(4):530–2.

    PubMed  Google Scholar 

  73. Reed KB, Davis MD. Incidence of erythromelalgia: a population-based study in Olmsted County Minnesota. J Eur Acad Dermatol Venereol. 2009;23(1):13–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  74. Drenth JP, Michiels JJ. Erythromelalgia and erythermalgia: diagnostic differentiation. Int J Dermatol. 1994;33(6):393–7.

    PubMed  CAS  Google Scholar 

  75. Cook-Norris RH, Tollefson MM, Cruz-Inigo AE, Sandroni P, Davis MD, Davis DM. Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period. J Am Acad Dermatol. 2012;66(3):416–23.

    PubMed  Google Scholar 

  76. Mork C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000;114(4):643–6.

    PubMed  CAS  Google Scholar 

  77. Berlin AL, Pehr K. Coexistence of erythromelalgia and Raynaud’s phenomenon. J Am Acad Dermatol. 2004;50(3):456–60.

    PubMed  Google Scholar 

  78. Paira S, Cassano G, Korol V, Ortiz A, Roverano S. Erythromelalgia with subsequent digital necrosis, glomerulonephritis, and antiphospholipid antibodies. J Clin Rheumatol. 2005;11(4):209–12.

    PubMed  Google Scholar 

  79. Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop Relat Res. 1979;144:249–54.

    PubMed  Google Scholar 

  80. van Genderen PJ, Michiels JJ. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost. 1997;23(4):357–63.

    PubMed  Google Scholar 

  81. Michiels JJ, Drenth JP. Erythromelalgia and erythermalgia: lumpers and splitters. Int J Dermatol. 1994;33(6):412–3.

    PubMed  CAS  Google Scholar 

  82. Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med. 1989; 149(1):105–9.

    PubMed  CAS  Google Scholar 

  83. Kurzrock R, Cohen PR. Paraneoplastic erythromelalgia. Clin Dermatol. 1993;11(1):73–82.

    PubMed  CAS  Google Scholar 

  84. Michiels JJ, van Joost T. Erythromelalgia and thrombocythemia: a causal relation. J Am Acad Dermatol. 1990;22(1):107–11.

    PubMed  CAS  Google Scholar 

  85. Davis MD, Rooke TW, Sandroni P. Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia. J Invest Dermatol. 2000;115(6):1166–7.

    PubMed  CAS  Google Scholar 

  86. Genebriera J, Michaels JD, Sandroni P, Davis MD. Results of computer-assisted sensory evaluation in 41 patients with erythromelalgia. Clin Exp Dermatol. 2012;37(4):350–4.

    PubMed  CAS  Google Scholar 

  87. Davis MD, Rooke T. Erythromelalgia. Curr Treat Options Cardiovasc Med. 2006;8(2):153–65.

    PubMed  Google Scholar 

  88. Peet RM, Henriksen JD, Anderson TP, Martin GM. Thoracic outlet syndrome: evaluation of a therapeutic exercise program. Proc Staff Meet Mayo Clin. 1956;31:281–7.

    PubMed  CAS  Google Scholar 

  89. Stopford JS, Telford ED. Compression of the lower trunk of the brachial plexus by a first dorsal rib: with a note on the surgical treatment. Br J Surg. 1919;7:168–77.

    Google Scholar 

  90. Eden KC. Complications of cervical rib: vascular complications of cervical ribs and first thoracic rib abnormalities. Br J Surg. 1939/1940;27:111–39.

    Google Scholar 

  91. Cormier JM, Amrane M, Ward A, Laurian C, Gigou F. Arterial complications of thoracic outlet syndrome. J Vasc Surg. 1989;9:778–87.

    PubMed  CAS  Google Scholar 

  92. Hood DB, Kuehne J, Yellin AE, Weaver FA. Vascular complications of thoracic outlet syndrome. Am Surg. 1997;63:913–7.

    PubMed  CAS  Google Scholar 

  93. Sanders RJ, Hammond SL, Rao NM. Thoracic outlet syndrome: a review. Neurologist. 2008;14:365–73.

    PubMed  Google Scholar 

  94. Kai Y, Oyama M, Kurose S, Inadome T, Oketani Y, Masuda Y. Neurogenic thoracic outlet syndrome in whiplash injury. J Spinal Disord. 2001;14:487–93.

    PubMed  CAS  Google Scholar 

  95. Sanders RJ, Haug CE. Thoracic outlet syndrome: a common sequela of neck injuries. In: Thoracic outlet syndrome. Philadelphia: Lippinoctt; 1991:26.

    Google Scholar 

  96. Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg. 2007;46:601–4.

    PubMed  Google Scholar 

  97. Stapleton C, Herrington L, George K. Sonographic evaluation of the subclavian artery during thoracic outlet syndrome shoulder maneuvers. Man Ther. 2009;14:19–27.

    PubMed  Google Scholar 

  98. Brantigan CO, Roos DB. Diagnosing thoracic outlet syndrome. Hand Clin. 2004;20:27–36.

    PubMed  Google Scholar 

  99. Filler AG, Maravilla KR, Tsuruda JS. MR neurography and muscle MR imaging for image diagnosis of disorders affecting the peripheral nerves and musculature. Neurol Clin. 2004;22:643–82.

    PubMed  Google Scholar 

  100. Brooke BS, Freischlag JA. Contemporary management of thoracic outlet syndrome. Curr Opin Cardiol. 2010;25:535–40.

    PubMed  Google Scholar 

  101. Jordan SE, Machieder HI. Diagnosis of thoracic outlet syndrome using electrophysiologically guided anterior scalene blocks. Ann Vasc Surg. 1998;12:260–4.

    PubMed  CAS  Google Scholar 

  102. Torriani M, Gupta R, Donahue DM. Sonographically guided anesthetic injection of anterior scalene muscles for treatment of neurogenic thoracic outlet syndrome. Ann Vasc Surg. 2000;14:365–9.

    Google Scholar 

  103. Criado E, Berguer R, Greenfield L. The spectrum of arterial compression at the thoracic outlet. J Vasc Surg. 2010;52:406–11.

    PubMed  Google Scholar 

  104. Jordan SE, Ahn SS, Freischlag JA, Gelabert HA, Machleder HI. Selective botulinum chemodenervation of the scalene muscles for treatment of neurogenic thoracic outlet syndrome. Ann Vasc Surg. 2000;14:365–9.

    PubMed  CAS  Google Scholar 

  105. Christo PJ, Christo DK, Carinci AJ, Freischlag JA. Single CT-guided chemodenervation of the anterior scalene muscle with botulism toxin for neurogenic thoracic outlet syndrome. Pain Med. 2010;11:504–11.

    PubMed  Google Scholar 

  106. Torriani M, Gupta R, Donahue DM. Botulinum toxin injection in neurogenic thoracic outlet syndrome: results and experience using an ultrasound-guided approach. Skeletal Radiol. 2010;39:973–80.

    PubMed  Google Scholar 

  107. Lee JT, Karwowski JK, Harris EJ, Haukoos JS, Olcott 4th C. Long-term thrombotic recurrence after nonoperative management of Paget-Schroetter syndrome. J Vasc Surg. 2006;43:1236–43.

    PubMed  Google Scholar 

  108. Molina JE, Hunter DW, Dietz CA. Paget-Schroetter syndrome treated with thrombolytics and immediate surgery. J Vasc Surg. 2007;45:328–34.

    PubMed  Google Scholar 

  109. de Leon RA, Chang DC, Hassoun HT, Black JH, Roseborough GS, Perler BA, et al. Multiple treatment algorithms for successful outcomes in venous thoracic outlet syndrome. Surgery. 2009;145:500–7.

    PubMed  Google Scholar 

  110. Caparrelli DJ, Freischlag J. A unified approach to axillosubclavian venous thrombosis in a single hospital admission. Semin Vasc Surg. 2005;18:153–7.

    PubMed  Google Scholar 

  111. Urschel HC, Raazzuk MA. Paget-Schroetter syndrome: what is the best management? Ann Thorac Surg. 2000;69:1663–9.

    PubMed  Google Scholar 

  112. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle, WA: IASP Press; 1994.

    Google Scholar 

  113. Bruehl S, Harden RN, Galer BS, Saltz S, Backonja M, Stanton-Hicks M. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain. 2002;95:119–24.

    PubMed  Google Scholar 

  114. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy, prospective study of 829 patients. Lancet. 1993;342:1012–6.

    PubMed  CAS  Google Scholar 

  115. de Boer RD, Marinus J, van Hilten JJ, Huygen FJ, van Eijs F, van Kleef M, et al. Distribution of signs and symptoms of complex regional pain syndrome type I in patients meeting the diagnostic criteria of the International Association for the Study of Pain. Eur J Pain. 2011;15:831–8.

    Google Scholar 

  116. Van Laere M, Claessens M. The treatment of reflex sympathetic dystrophy syndrome: current concepts. Acta Orthop Belg. 1992;58 Suppl 1:259–61.

    PubMed  Google Scholar 

  117. Cohen H, McCabe C, Harris N, Hall J, Lewis J, Blake DR. Clinical evidence of parietal cortex dysfunction and correlation with extent of allodynia in CRPS type I. Eur J Pain. 2013;17:527–38.

    PubMed  CAS  Google Scholar 

  118. Acerra NE, Moseley GL. Dysynchiria: watching the mirror image of the unaffected limb elicits pain on the affected side. Neurology. 2005;65:751–3.

    PubMed  Google Scholar 

  119. Harden NR, Bruehl S, Perez R. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010;150(2):268–74.

    PubMed  PubMed Central  Google Scholar 

  120. Chleimsky TC, Low PA, Naessens JM, Wilson PR, Amadio PC, O’Brien PC. Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc. 1995;70:1029–40.

    Google Scholar 

  121. Lee GW, Weeks PM. The role of bone scintigraphy in diagnosing reflex sympathetic dystrophy. J Hand Surg Am. 1995;20:458–63.

    PubMed  CAS  Google Scholar 

  122. Cappello ZJ, Kasdan ML, Louis DS. Meta-analysis of imaging techniques for the diagnosis of complex regional pain syndrome type I. J Hand Surg Am. 2012;37:288–96.

    PubMed  Google Scholar 

  123. Varenna M, Adami S, Rossini M, Gatti D, Idolazzi L, Zucchi F, et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double blind placebo-controlled study. Rheumatology (Oxford). 2013;52:534–42.

    CAS  Google Scholar 

  124. O’Connell NE, Wand BM, McAuley J, Marston L, Moseley GL. Interventions for treating pain and disability in adults with complex regional pain syndrome – an overview of systematic reviews. Cochrance Database Syst Rev. 2013;4, CD009416.

    Google Scholar 

  125. Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev. 2013;13(3):242–65. http://dx.doi.org; 10.1016/j.autrev.2013.10.0006.

    PubMed  Google Scholar 

Download references

Acknowledgement

 We acknowledge Dr. Stefan Zimmeran for his image of arterial thoracic outlet syndrome as shown in (Fig. 11.9).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zsuzsanna H. McMahan M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

McMahan, Z.H., Paik, J.J. (2015). Raynaud’s Mimics. In: Wigley, F., Herrick, A., Flavahan, N. (eds) Raynaud’s Phenomenon. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1526-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1526-2_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1525-5

  • Online ISBN: 978-1-4939-1526-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics